logologo
QuantliQuantli

Vericel Corp

VCEL

NASDAQ

Biotechnology

$44.20

USD

-0.34 (-0.76%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $2.26B

Volume 276.1K

Price Target

$72.00$72.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $72.00 and a min estimate of $72.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$72.00

+$19.0 vs prior

Implied Upside

+62.9%

+43.0% vs prior

Analyst Covering

1

-1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

33%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Swayampakula Ramakanth

HC Wainwright & Co.

Buy

Maintained

2 weeks ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BCRX

BioCryst Pharmaceuticals Inc

$9.74

-0.7%

PVLA

Palvella Therapeutics Inc

$156.13

-0.3%

CDNA

CareDx Inc

$45.32

-4.3%

COAG

Hemab Therapeutics Holdings Inc

$54.94

+1.8%

MLYS

Mineralys Therapeutics Inc

$25.64

-1.7%

PGEN

Precigen Inc

$6.10

-6.0%

VERA

Vera Therapeutics, Inc

$31.63

+9.5%

KLRA

Kailera Therapeutics Inc

$17.94

-0.2%